NeuroMetrix, a medical device company, and Omron Medical Devices, a subsidiary of Omron Healthcare China, have entered into an agreement for the distribution of NC-stat DPNCheck in China. Pursuant to the terms of the agreement, ...
Tags: Medical Devices, Medicine
The US Food and Drug Administration (FDA) has approved Alere's pre-market application (PMA) for the commercialization of Alere Determine HIV 1/2 Ag/Ab Combo in the country. The FDA approval allows the marketing of Alere Determine HIV 1/2 ...
Tags: Alere Determine, Medicine
The US Food and Drug Administration (FDA) has approved the first rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 antigen in human serum, plasma, and venous or fingerstick whole blood specimens. The Alere ...
Tags: Rapid Diagnostic Test, HIV-1, HIV-2
Omron Healthcare has entered into an agreement to distribute NeuroMetrix's NC-stat DPNCheck in Japan. Designed to detect diabetic peripheral neuropathy at an early stage, the quantitative point-of-care test NC-stat DPNCheckmn allows ...
Serascience, a joint venture between Abingdon Health and the University of Birmingham, has introduced a proprietary point-of-care diagnostic device for multiple myeloma. Designed to aid in the diagnosis of myeloma and monitor relapse and ...
The British Standards Institute (BSI) has awarded ISO 13485: 2003 certification to Zyomyx's quality management system. Zyomyx is involved in developing and commercializing proprietary diagnostic platforms including quantitative disposable ...
Tags: Zyomyx, CD4 diagnostics, proprietary diagnostic platforms
California-based technology-enabled service company FirstVitals Health and Wellness has received a non-invasive technology, designed for diagnosis of diabetic neuropathy, from NeuroMetrix to supplement its Centers for Medicare and Medicaid ...
Tags: NeuroMetrix, diagnostic technology, FirstVitals Health
Argutus Medical was chosen as one of ten companies to display their latest product at the Innovators Place™ during the American Society of Nephrology (ASN) Kidney Week 2012. The scientific exposition, which took place from the 1st ...
Tags: AKI Test, Innovators Place, Argutus Medical
Roche Diagnostics is planning to invest $300m over the next 10 years to expand operation at its headquarters in Indianapolis, Indiana, US. Roche produces 2 billion strips of ACCU-CHEK products as well as develop and manufacture ...
Tags: Roche, expand operation, headquarters, diabetes care businesses
Province of Manitoba, under its commercialization support for business (CSB) program, will fund $130,000 grant to Miraculins to support the commercialization of PreVu non-invasive skin cholesterol test. The PreVu point of care test is a ...
Tags: non-invasive skin cholesterol test, CSB program, care test